Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.
作者信息
Kwaan H C
出版信息
Thromb Diath Haemorrh Suppl. 1973;56:239-51.
PMID:4617331
Abstract
摘要
相似文献
1
Use of defibrinating agents ancrod and reptilase in the treatment of thromboembolism.去纤维蛋白原制剂安克洛酶和蝮蛇抗栓酶在血栓栓塞治疗中的应用。
Thromb Diath Haemorrh Suppl. 1973;56:239-51.
2
The hematologic consequences of thrombolytic therapy.溶栓治疗的血液学后果。
Prog Hematol. 1986;14:183-200.
3
In vitro potentiation of urokinase-activated lysis of human fibrin clots.尿激酶激活的人纤维蛋白凝块溶解的体外增强作用。
J Med. 1974;5(6):297-302.
4
Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.关于矛头蝮蛇毒类凝血酶的实验与临床研究。片段E的一级结构。
Acta Physiol Scand Suppl. 1973;400:1-47.
5
Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.抗栓酶抗凝机制。对纤维蛋白的直接蛋白水解作用。
J Clin Invest. 1972 Nov;51(11):2841-50. doi: 10.1172/JCI107107.
6
New approach to thrombolytic therapy: the use of Defibrase in connection with streptokinase.溶栓治疗的新方法：去纤酶与链激酶联合使用。
Thromb Diath Haemorrh Suppl. 1973;56:253-64.
7
[Clinical use of thrombolytic agents].[溶栓药物的临床应用]
Agressologie. 1983 Nov;24(11):559-65.
8
Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.抗凝药和溶栓药。I. 病理生理学和药理学方面。
Drugs. 1971;1(3):228-46. doi: 10.2165/00003495-197101030-00003.
9
[Thromboembolism and fibrinolytic therapy].[血栓栓塞与纤维蛋白溶解疗法]
Z Arztl Fortbild (Jena). 1978 Apr 15;72(8):357-65.
10
[Systemic effects of thrombolytic therapy].[溶栓治疗的全身效应]
Haematologica. 1991 Jun;76 Suppl 3:281-90.
引用本文的文献
1
Defibrinogenating enzymes.去纤维蛋白原酶
Drugs. 1997;54 Suppl 3:18-30; discussion 30-1. doi: 10.2165/00003495-199700543-00005.
2
Inhibition of the arrest of hematogenously disseminated tumor cells.抑制血行播散肿瘤细胞的滞留。
Cancer Metastasis Rev. 1983;2(3):223-37. doi: 10.1007/BF00048479.
Zotero 插件